Altimmune Inc Phase 2 AUD Trial For Pemvidutide Expected In Q2 2025

Published: 2025-03-13 17:33:37 ET ALT

March 13 (Reuters) - Altimmune Inc:

* ALTIMMUNE INC - PHASE 2 AUD TRIAL FOR PEMVIDUTIDE EXPECTED IN Q2 2025 Further company coverage: